SS Innovations International (SSII) Current Deferred Revenue (2022 - 2026)
SS Innovations International's (SSII) quarterly Current Deferred Revenue came in at $3.6 million in Q1 2026, down 50.76% year-on-year from $7.3 million in Q1 2025, and up 9.67% quarter-over-quarter from $3.3 million in Q4 2025.
SS Innovations International (SSII) Current Deferred Revenue (2022 - 2026) Analysis & Trends
SS Innovations International has disclosed Current Deferred Revenue across 5 years of filings, most recently posting $3.6 million for Q1 2026.
- Current Deferred Revenue for Q1 2026 came in at $3.6 million, down 50.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.6 million (down 50.76% YoY), and the FY2025 annual result was $3.3 million, down 49.37% from the prior year.
- Current Deferred Revenue came in at $3.6 million for Q1 2026 at SS Innovations International, up from $3.3 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $1095.5 billion in Q4 2023 to a low of $43917.0 in Q4 2022.
- The 5-year median for Current Deferred Revenue is $3.3 million (2025), against an average of $84.3 billion.
- Across the five-year window, Current Deferred Revenue surged 2494432579.83% in 2023 and plunged 100.0% in 2024, its largest moves.
- SS Innovations International's Current Deferred Revenue stood at $43917.0 in 2022, then soared by 2494432579.83% to $1095.5 billion in 2023, then slumped by 100.0% to $6.5 million in 2024, then plunged by 49.37% to $3.3 million in 2025, then advanced by 9.67% to $3.6 million in 2026.
- The last three Current Deferred Revenue figures came in at $3.6 million (Q1 2026), $3.3 million (Q4 2025), and $8.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | SS Innovations International | 689.95 Mn | 666.34 Mn | 5.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.58 Mn |
| Dec 31, 2025 | 3.27 Mn |
| Sep 30, 2025 | 8.79 Mn |
| Jun 30, 2025 | 2.41 Mn |
| Mar 31, 2025 | 7.28 Mn |
| Dec 31, 2024 | 6.45 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 4.13 Mn |
| Mar 31, 2024 | 252,265.00 |
| Dec 31, 2023 | 1,095.48 Bn |
| Sep 30, 2023 | 92,729.00 |
| Jun 30, 2023 | 386,623.00 |
| Dec 31, 2022 | 43,917.00 |